<?xml version="1.0" encoding="UTF-8"?>
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         article-type="news"
         dtd-version="1.1"
         specific-use="production"
         xml:lang="en">
   <front>
      <journal-meta>
         <journal-id journal-id-type="publisher">Psychosomatic Medicine and General Practice</journal-id>
         <issn>2519-8572</issn>
		 <journal-title-group>
			<journal-title>Psychosomatic Medicine and General Practice</journal-title>
		 </journal-title-group>
         <publisher>
            <publisher-name>Private Publisher 'Chaban O. S.'</publisher-name>
         </publisher>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="publisher-id">106</article-id>
         <article-categories>
            <subj-group>
               <subject>analgetics</subject>
			   <subject>General Practice</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title>Acetaminophen (paracetamol) reduces sex hormones level</article-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author">
               <name name-style="western">
                  <surname>Bezsheiko</surname>
                  <given-names>Vitaliy</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
               <xref ref-type="corresp" rid="cor1"/>
            </contrib>
            <aff id="aff1">
               <institution content-type="dept">Department of Psychosomatic Medicine and Psychotherapy, Bogomolets National Medical University</institution>
               <addr-line>
                  <named-content content-type="city">Kyiv</named-content>
               </addr-line>
               <country>Ukraine</country>
            </aff>
         </contrib-group>
         <author-notes>
            <corresp id="cor1">
               <email>a@e-medjournal.com</email>
            </corresp>
         </author-notes>
         <pub-date date-type="pub" iso-8601-date="2018-02-21" publication-format="print">
            <day>21</day>
            <month>2</month>
            <year>2018</year>
         </pub-date>
         <volume>3</volume>
         <issue>1</issue>
         <elocation-id>e0301106</elocation-id>
         <permissions>
            <copyright-statement>© 2017,</copyright-statement>
            <copyright-year>2017</copyright-year>
            <copyright-holder> </copyright-holder>
            <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
               <license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri"
                            xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
            </license>
         </permissions>
         <abstract abstract-type="short">
		   <title>Abstract</title>
		   <p>Medication was not as safe as previously thought</p>
         </abstract>
         <kwd-group kwd-group-type="author-keywords">
            <title>Keywords</title>
            <kwd>paracetamol</kwd>
            <kwd>acetaminophen</kwd>
            <kwd>sex hormones</kwd>
         </kwd-group>
      </article-meta>
   </front>
   <body>
      <sec>
         <title>Background</title>
         <p>Acetaminophen (paracetamol) is one of the most used drugs in the world. It is used primarily as an analgesic and antipyretic agent. According to the current clinical guidelines, this drug can be used to treat adults and children. Recommendations for the use of acetaminophen during pregnancy are controversial, but, for example, FDA warns only about the heightened risk of attention deficit disorder in case of long-term use by pregnant women <xref ref-type="bibr" rid="bib1">1</xref>.</p>
         <p>According to the results of systematic reviews, the use of this drug is not associated with an increased risk of severe side effects, and 2 Cochrane reviews did not demonstrate any significant increase in the risk even of any side effects when compared to placebo in adults and children <xref ref-type="bibr" rid="bib2">2</xref>, <xref ref-type="bibr" rid="bib3">3</xref>; although, these results are relating only to short-term treatment.</p>
      </sec>
      <sec>
         <title>Results of the new study</title>
         <p>Unexpected results were obtained by a group of scientists led by Isaac Cohen from the University of California San Diego <xref ref-type="bibr" rid="bib4">4</xref>. The researchers analyzed effects of the acetaminophen by observing metabolic profile in 3570 individuals. Scientists were able to study the changes in more than 700 metabolites in response to the medication.</p>
         <p>According to the researchers, they had hoped to see changes in markers associated with the liver function as a response to acetaminophen intake. Instead, they observed quite substantial changes in sex hormones level. Thus, the reduction concerned androgenic steroids (dehydroisoandrosterone sulfate, androstenediol monosulfat, etс.), pregnenolone steroids (pregnenolone sulfate and others), and progestin steroids (pregnen-diol sulfate and others).</p>
         <p>Most of the sample consisted of twins. Comparison of the medication’s and other environmental effects on twins (when one twin is exposed and other - doesn’t) is one of the essential research methods in medicine, which helps to exclude genes influence. Data analysis confirmed that that twin who took the drug had lower levels of sex sulfate hormones.</p>
         <p>Scientists were able to identify that acetaminophen and estrogens are metabolized by the same family of enzymes responsible for catalysis of various exogenous and endogenous metabolites. Moreover, it’s quite probable that these substances are metabolized by the same representative of this family - SULT1A1.</p>
      </sec>
      <sec>
         <title>Conclusion</title>
         <p>It should be noted that without clear clinical data it is difficult to establish negative impact acetaminophen on metabolic health. In the interview with «Medscape,» one of the research team members pointed that women who were taking this drug had a reduced pregnen-diol sulfate to levels usually observed at the physiological age of 35 years. <bold>However, importantly, these changes were short-lived, and this levels returned to normal within a few days after the last drug intake </bold><xref ref-type="bibr" rid="bib5">5</xref>.</p>
         <p>On the other hand, the changes in hormonal status may seriously harm fetal development. Especially in the case of long-term treatment. According to scientists, this requires further research.</p>
      </sec>
	  <sec>
		<title>Additional information</title>
		<sec>
			<title>Competing interests</title>
			<p>The author declares that no competing interests exist.</p>
		</sec>
	  </sec>
   </body>
   <back>
      <ref-list>
         <title>References</title>
         <ref id="bib1">
            <element-citation publication-type="journal">
               <person-group person-group-type="author">
                  <collab>US Food and Drug Administration</collab>
               </person-group>
			   <article-title>FDA Drug Safety Communication: FDA has reviewed possible risks of pain medicine use during pregnancy</article-title>
			   <source>FDA official site</source>
			   <year>2015</year>
               <ext-link ext-link-type="uri">https://www.fda.gov/Drugs/DrugSafety/ucm429117.htm</ext-link>
            </element-citation>
         </ref>
         <ref id="bib2">
            <element-citation publication-type="journal">
               <person-group person-group-type="author">
                  <name>
                     <surname>Stephens</surname>
                     <given-names>G</given-names>
                  </name>
                  <name>
                     <surname>Derry</surname>
                     <given-names>S</given-names>
                  </name>
                  <name>
                     <surname>Moore</surname>
                     <given-names>RA</given-names>
                  </name>
               </person-group>
               <article-title>Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults</article-title>
               <source>Cochrane Database Syst Rev</source>
               <year>2016</year>
               <volume>16</volume>
               <issue>6</issue>
               <fpage>CD011889</fpage>
               <pub-id pub-id-type="doi">10.1002/14651858.CD011889.pub2</pub-id>
               <pub-id pub-id-type="pmid">https://www.ncbi.nlm.nih.gov/pubmed/27306653</pub-id>
            </element-citation>
         </ref>
         <ref id="bib3">
            <element-citation publication-type="journal">
               <person-group person-group-type="author">
                  <name>
                     <surname>Sjoukes</surname>
                     <given-names>A</given-names>
                  </name>
                  <name>
                     <surname>Venekamp</surname>
                     <given-names>RP</given-names>
                  </name>
                  <name>
                     <surname>Pol</surname>
                     <given-names>AC</given-names>
                  </name>
                  <name>
                     <surname>Hay</surname>
                     <given-names>AD</given-names>
                  </name>
                  <name>
                     <surname>Little</surname>
                     <given-names>P</given-names>
                  </name>
                  <name>
                     <surname>Schilder</surname>
                     <given-names>AG</given-names>
                  </name>
                  <name>
                     <surname>Damoiseaux</surname>
                     <given-names>RA</given-names>
                  </name>
               </person-group>
               <article-title>Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children</article-title>
               <source>Cochrane Database Syst Rev</source>
               <year>2016</year>
               <volume>12</volume>
               <fpage>CD011534</fpage>
               <pub-id pub-id-type="doi">10.1002/14651858.CD011534.pub2</pub-id>
               <pub-id pub-id-type="pmid">https://www.ncbi.nlm.nih.gov/pubmed/27977844</pub-id>
            </element-citation>
         </ref>
         <ref id="bib4">
            <element-citation publication-type="journal">
               <person-group person-group-type="author">
                  <name>
                     <surname>Cohen</surname>
                     <given-names>IV</given-names>
                  </name>
                  <name>
                     <surname>Cirulli</surname>
                     <given-names>ET</given-names>
                  </name>
                  <name>
                     <surname>Mitchell</surname>
                     <given-names>MW</given-names>
                  </name>
                  <name>
                     <surname>Jonsson</surname>
                     <given-names>TJ</given-names>
                  </name>
                  <name>
                     <surname>Yu</surname>
                     <given-names>J</given-names>
                  </name>
                  <name>
                     <surname>Shah</surname>
                     <given-names>N</given-names>
                  </name>
                  <name>
                     <surname>Spector</surname>
                     <given-names>TD</given-names>
                  </name>
                  <name>
                     <surname>Guo</surname>
                     <given-names>L</given-names>
                  </name>
                  <name>
                     <surname>Venter</surname>
                     <given-names>JC</given-names>
                  </name>
                  <name>
                     <surname>Telenti</surname>
                     <given-names>A</given-names>
                  </name>
               </person-group>
               <article-title>Acetaminophen (Paracetamol) Use Modifies the Sulfation of Sex Hormones</article-title>
               <source>EBioMedicine</source>
               <year>2018</year>
               <volume>28</volume>
               <fpage>316</fpage>
               <lpage>323</lpage>
               <pub-id pub-id-type="doi">10.1016/j.ebiom.2018.01.033</pub-id>
               <pub-id pub-id-type="pmid">https://www.ncbi.nlm.nih.gov/pubmed/29398597</pub-id>
            </element-citation>
         </ref>
         <ref id="bib5">
            <element-citation publication-type="journal">
               <person-group person-group-type="author">
                  <name>
                     <surname>Busko</surname>
                     <given-names>M</given-names>
                  </name>
               </person-group>
			   <article-title>Acetaminophen Use Alters Sex Hormones, May Cause Birth Defects?</article-title>
			   <source>Medscape</source>
			   <year>2018</year>
               <ext-link ext-link-type="uri">https://www.medscape.com/viewarticle/892824</ext-link>
            </element-citation>
         </ref>
      </ref-list>
   </back>
</article>
